Načítá se...
Sodium hydrosulfide mitigates dexamethasone‐induced osteoblast dysfunction by interfering with mitochondrial function
Osteoporosis is one of the clinical complications of long‐term treatment with glucocorticoids (GCs), characterized by systemic damage of bone mass and osteoblast dysfunction. Hydrogen sulfide was found to be involved in GCs‐induced osteoblast dysfunction. Osteoblastic MC3T3‐E1 cell and mitochondrial...
Uloženo v:
| Vydáno v: | Biotechnol Appl Biochem |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790666/ https://ncbi.nlm.nih.gov/pubmed/31173404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bab.1786 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|